Effect of a Combination of Magnesium, B Vitamins, Rhodiola, and Green Tea (L-Theanine) on Chronically Stressed Healthy Individuals-A Randomized, Placebo-Controlled Study
- PMID: 35565828
- PMCID: PMC9102162
- DOI: 10.3390/nu14091863
Effect of a Combination of Magnesium, B Vitamins, Rhodiola, and Green Tea (L-Theanine) on Chronically Stressed Healthy Individuals-A Randomized, Placebo-Controlled Study
Abstract
The effect of a combination of magnesium, vitamins B6, B9, B12, rhodiola and green tea/L-theanine (Mg-Teadiola) on stress was evaluated in chronically stressed, otherwise healthy individuals. Effects on stress-related quality-of-life parameters (sleep and perception of pain) were also explored. Adults with stress for ≥1 month, scoring ≥14 points on the Depression Anxiety Stress Scale (DASS)-42 questionnaire, were randomized (1:1) to receive oral Mg-Teadiola (n = 49) or a placebo (n = 51), for 28 days, with a follow-up assessment on Day 56 (NCT04391452). The primary endpoint was the change in the DASS-42 stress score from baseline to Day 28 with Mg-Teadiola versus placebo. The DASS-42 stress scores significantly decreased from baseline to Day 28 with Mg-Teadiola versus placebo (effect size, 0.29; 95% CI [0.01, 0.57]; p = 0.04). Similar reductions were observed on Day 14 (p = 0.006) and Day 56 (p = 0.02). A significant reduction in sensitivity to cold pain (p = 0.01) and a trend for lower sensitivity to warm pain was observed (p = 0.06) on Day 28. Improvements in daytime dysfunction due to sleepiness (Pittsburgh Sleep Quality Index-7 component score) were reported on Day 28, and were significant on Day 56 (p < 0.001). Mg-Teadiola is effective in managing stress in otherwise healthy individuals. Its beneficial effects on sleep and pain perception need further investigation.
Keywords: Depression Anxiety Stress Scale-42 questionnaire; L-theanine; Pittsburgh Sleep Quality Index; chronic stress; green tea; magnesium; pain; randomized clinical trial; rhodiola; vitamins.
Conflict of interest statement
L.N., C.B., and E.P. are employees of Sanofi and may hold shares and/or stock options in the company. G.P., V.M., B.P., C.D. and N.M. declare no conflict of interest.
Figures






References
-
- Mahmud S., Hossain S., Muyeed A., Islam M.M., Mohsin M. The global prevalence of depression, anxiety, stress, and, insomnia and its changes among health professionals during COVID-19 pandemic: A rapid systematic review and meta-analysis. Heliyon. 2021;7:e07393. doi: 10.1016/j.heliyon.2021.e07393. - DOI - PMC - PubMed
-
- Salari N., Hosseinian-Far A., Jalali R., Vaisi-Raygani A., Rasoulpoor S., Mohammadi M., Rasoulpoor S., Khaledi-Paveh B. Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: A systematic review and meta-analysis. Glob. Health. 2020;16:57. doi: 10.1186/s12992-020-00589-w. - DOI - PMC - PubMed
-
- MentalHealth.net An American Addiction Centers Resource. [(accessed on 22 December 2021)]. Available online: https://www.mentalhelp.net/stress/reduction/medication/
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical